{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T21:04:22Z","timestamp":1791234262883,"version":"4.1.0"},"reference-count":60,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001843","name":"Science and Engineering Research Board","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001843","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.antiviral.2020.104870","type":"journal-article","created":{"date-parts":[[2020,7,21]],"date-time":"2020-07-21T03:23:10Z","timestamp":1595301790000},"page":"104870","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":60,"special_numbering":"C","title":["Antiviral activity of Apigenin against buffalopox: Novel mechanistic insights and drug-resistance considerations"],"prefix":"10.1016","volume":"181","author":[{"given":"Nitin","family":"Khandelwal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yogesh","family":"Chander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ram","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thachamvally","family":"Riyesh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4111-953X","authenticated-orcid":false,"given":"Ramesh Kumar","family":"Dedar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manoj","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4338-7941","authenticated-orcid":false,"given":"Baldev R.","family":"Gulati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shalini","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhupendra N.","family":"Tripathi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjay","family":"Barua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naveen","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.antiviral.2020.104870_bib1","doi-asserted-by":"crossref","DOI":"10.1128\/genomeA.00444-18","article-title":"Complete genome sequence of buffalopox virus","volume":"6","author":"Afrough","year":"2018","journal-title":"Genome Announc."},{"key":"10.1016\/j.antiviral.2020.104870_bib2","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1128\/AAC.00749-06","article-title":"Development of a new methodology for screening of human immunodeficiency virus type 1 microbicides based on real-time PCR quantification","volume":"51","author":"Aguiar","year":"2007","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2020.104870_bib3","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1007\/s00405-008-0658-0","article-title":"Side-effects of cidofovir in the treatment of recurrent respiratory papillomatosis","volume":"265","author":"Broekema","year":"2008","journal-title":"Eur. Arch. Oto-Rhino-Laryngol."},{"key":"10.1016\/j.antiviral.2020.104870_bib4","doi-asserted-by":"crossref","first-page":"13135","DOI":"10.1128\/JVI.01883-14","article-title":"Induction of viral, 7-methyl-guanosine cap-independent translation and oncolysis by mitogen-activated protein kinase-interacting kinase-mediated effects on the serine\/arginine-rich protein kinase","volume":"88","author":"Brown","year":"2014","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2020.104870_bib5","doi-asserted-by":"crossref","first-page":"16900","DOI":"10.1073\/pnas.0804525105","article-title":"Crystal structure of poxvirus thymidylate kinase: an unexpected dimerization has implications for antiviral therapy","volume":"105","author":"Caillat","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.antiviral.2020.104870_bib6","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.jhep.2010.01.041","article-title":"HCV resistance to cyclosporin A does not correlate with a resistance of the NS5A-cyclophilin A interaction to cyclophilin inhibitors","volume":"53","author":"Chatterji","year":"2010","journal-title":"J. Hepatol."},{"key":"10.1016\/j.antiviral.2020.104870_bib7","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1128\/AAC.00939-08","article-title":"Debio 025, a cyclophilin binding molecule, is highly efficient in clearing hepatitis C virus (HCV) replicon-containing cells when used alone or in combination with specifically targeted antiviral therapy for HCV (STAT-C) inhibitors","volume":"53","author":"Coelmont","year":"2009","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2020.104870_bib8","series-title":"Antiviral Efficacy of Flavonoids against Enterovirus 71 Infection in Vitro and in Newborn Mice","author":"Dai","year":"2019"},{"key":"10.1016\/j.antiviral.2020.104870_bib9","doi-asserted-by":"crossref","first-page":"187","DOI":"10.4103\/0974-777X.81698","article-title":"Outbreak of human buffalopox infection","volume":"3","author":"Damle","year":"2011","journal-title":"J. Global Infect. Dis."},{"key":"10.1016\/j.antiviral.2020.104870_bib10","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1128\/CMR.14.2.382-397.2001","article-title":"Vaccinia virus inhibitors as a paradigm for the chemotherapy of poxvirus infections","volume":"14","author":"De Clercq","year":"2001","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.antiviral.2020.104870_bib11","first-page":"683","article-title":"A note on the attenuation of buffalopox virus","volume":"19","author":"Dogra","year":"1981","journal-title":"Indian J. Exp. Biol."},{"key":"10.1016\/j.antiviral.2020.104870_bib12","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/BF01309438","article-title":"Virological investigations of specimens from buffaloes affected by buffalopox in Maharashtra State, India between 1985 and 1987","volume":"128","author":"Dumbell","year":"1993","journal-title":"Arch. Virol."},{"key":"10.1016\/j.antiviral.2020.104870_bib13","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1080\/14786419.2017.1419227","article-title":"Chemical and Biological insights of Ouratea hexasperma (A. St.-Hil.) Baill.: a source of bioactive compounds with multifunctional properties","volume":"33","author":"Fidelis","year":"2019","journal-title":"Nat. Prod. Res."},{"key":"10.1016\/j.antiviral.2020.104870_bib14","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1056\/NEJMoa1705688","article-title":"Oral Tecovirimat for the treatment of smallpox","volume":"379","author":"Grosenbach","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.antiviral.2020.104870_bib16","doi-asserted-by":"crossref","first-page":"348","DOI":"10.4103\/ijdvl.IJDVL_222_17","article-title":"A case report of buffalopox: a zoonosis of concern","volume":"85","author":"Gujarati","year":"2019","journal-title":"Indian J. Dermatol. Venereol. Leprol."},{"key":"10.1016\/j.antiviral.2020.104870_bib17","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.prevetmed.2011.03.008","article-title":"Buffalopox outbreak in humans and animals in Western Maharashtra, India","volume":"100","author":"Gurav","year":"2011","journal-title":"Prev. Vet. Med."},{"key":"10.1016\/j.antiviral.2020.104870_bib18","doi-asserted-by":"crossref","first-page":"3445","DOI":"10.1007\/s00705-016-3061-y","article-title":"Apigenin inhibits African swine fever virus infection in vitro","volume":"161","author":"Hakobyan","year":"2016","journal-title":"Arch. Virol."},{"key":"10.1016\/j.antiviral.2020.104870_bib19","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1002\/hep.27815","article-title":"Selection of a hepatitis C virus with altered entry factor requirements reveals a genetic interaction between the E1 glycoprotein and claudins","volume":"62","author":"Hopcraft","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.antiviral.2020.104870_bib20","doi-asserted-by":"crossref","first-page":"137","DOI":"10.4161\/rna.18827","article-title":"Liver-specific microRNA-122: biogenesis and function","volume":"9","author":"Jopling","year":"2012","journal-title":"RNA Biol."},{"key":"10.1016\/j.antiviral.2020.104870_bib21","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1638\/1042-7260(2000)031[0412:CPAATF]2.0.CO;2","article-title":"Clinical presentation and antiviral therapy for poxvirus infection in pudu (Pudu puda)","volume":"31","author":"Junge","year":"2000","journal-title":"J. Zoo Wildl. Med."},{"key":"10.1016\/j.antiviral.2020.104870_bib22","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/nrd.2017.162","article-title":"Host-directed therapies for bacterial and viral infections","volume":"17","author":"Kaufmann","year":"2018","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.antiviral.2020.104870_bib23","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.antiviral.2017.06.006","article-title":"Emetine inhibits replication of RNA and DNA viruses without generating drug-resistant virus variants","volume":"144","author":"Khandelwal","year":"2017","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2020.104870_bib24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.virusres.2014.06.011","article-title":"Silver nanoparticles impair Peste des petits ruminants virus replication","volume":"190","author":"Khandelwal","year":"2014","journal-title":"Virus Res."},{"key":"10.1016\/j.antiviral.2020.104870_bib25","doi-asserted-by":"crossref","first-page":"2556","DOI":"10.1099\/jgv.0.000921","article-title":"Heparan sulfate as a receptor for poxvirus infections and as a target for antiviral agents","volume":"98","author":"Khanna","year":"2017","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.antiviral.2020.104870_bib26","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1196\/annals.1352.014","article-title":"Anti-HIV, anti-poxvirus, and anti-SARS activity of a nontoxic, acidic plant extract from the Trifollium species Secomet-V\/anti-vac suggests that it contains a novel broad-spectrum antiviral","volume":"1056","author":"Kotwal","year":"2005","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.antiviral.2020.104870_bib27","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0156110","article-title":"Complexities in isolation and purification of multiple viruses from mixed viral infections: viral interference, persistence and exclusion","volume":"11","author":"Kumar","year":"2016","journal-title":"PloS One"},{"key":"10.1016\/j.antiviral.2020.104870_bib28","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3389\/fmicb.2019.00209","article-title":"Inhibitor of sarco\/endoplasmic reticulum calcium-ATPase impairs multiple steps of paramyxovirus replication","volume":"10","author":"Kumar","year":"2019","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.antiviral.2020.104870_bib29","doi-asserted-by":"crossref","first-page":"2818","DOI":"10.1128\/JVI.01969-10","article-title":"Receptor tyrosine kinase inhibitors block multiple steps of influenza a virus replication","volume":"85","author":"Kumar","year":"2011","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2020.104870_bib30","doi-asserted-by":"crossref","first-page":"5553","DOI":"10.1128\/AAC.00725-11","article-title":"Receptor tyrosine kinase inhibitors that block replication of influenza a and other viruses","volume":"55","author":"Kumar","year":"2011","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2020.104870_bib31","doi-asserted-by":"crossref","DOI":"10.1128\/CMR.00168-19","article-title":"Host-directed antiviral therapy","volume":"33","author":"Kumar","year":"2020","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.antiviral.2020.104870_bib32","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.antiviral.2018.10.022","article-title":"MNK1 inhibitor as an antiviral agent suppresses buffalopox virus protein synthesis","volume":"160","author":"Kumar","year":"2018","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2020.104870_bib33","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.virusres.2018.05.028","article-title":"Role of MAPK\/MNK1 signaling in virus replication","volume":"253","author":"Kumar","year":"2018","journal-title":"Virus Res."},{"key":"10.1016\/j.antiviral.2020.104870_bib34","doi-asserted-by":"crossref","first-page":"2740","DOI":"10.3390\/v2122740","article-title":"Development of CMX001 for the treatment of poxvirus infections","volume":"2","author":"Lanier","year":"2010","journal-title":"Viruses"},{"key":"10.1016\/j.antiviral.2020.104870_bib35","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1097\/00001432-200404000-00003","article-title":"Zoonotic poxvirus infections in humans","volume":"17","author":"Lewis-Jones","year":"2004","journal-title":"Curr. Opin. Infect. Dis."},{"key":"10.1016\/j.antiviral.2020.104870_bib36","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1093\/molehr\/gat015","article-title":"Dietary phytophenols curcumin, naringenin and apigenin reduce infection-induced inflammatory and contractile pathways in human placenta, foetal membranes and myometrium","volume":"19","author":"Lim","year":"2013","journal-title":"Mol. Hum. Reprod."},{"key":"10.1016\/j.antiviral.2020.104870_bib37","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1111\/ijd.13890","article-title":"Isolation and molecular characterization of zoonotic Buffalopox virus from skin lesions of humans in India","volume":"57","author":"Marinaik","year":"2018","journal-title":"Int. J. Dermatol."},{"key":"10.1016\/j.antiviral.2020.104870_bib38","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1128\/AAC.45.1.84-87.2001","article-title":"Efficacy of 2-amino-7-(1,3-dihydroxy-2-propoxymethyl)purine for treatment of vaccinia virus (orthopoxvirus) infections in mice","volume":"45","author":"Neyts","year":"2001","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2020.104870_bib39","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1080\/14786419.2015.1079189","article-title":"Phytochemical analysis of non-volatile fraction of Artemisia caerulescens subsp. densiflora (Viv.) (Asteraceae), an endemic species of La Maddalena Archipelago (Sardinia--Italy)","volume":"30","author":"Ornano","year":"2016","journal-title":"Nat. Prod. Res."},{"key":"10.1016\/j.antiviral.2020.104870_bib40","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.3390\/v7041613","article-title":"Apigenin restricts FMDV infection and inhibits viral IRES driven translational activity","volume":"7","author":"Qian","year":"2015","journal-title":"Viruses"},{"key":"10.1016\/j.antiviral.2020.104870_bib41","doi-asserted-by":"crossref","first-page":"324","DOI":"10.3201\/eid2002.130358","article-title":"Laboratory-acquired buffalopox virus infection, India","volume":"20","author":"Riyesh","year":"2014","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.antiviral.2020.104870_bib42","first-page":"1812","article-title":"The antiviral resistance and replication of cidofovir-resistant adenovirus variants in the New Zealand White rabbit ocular model","volume":"42","author":"Romanowski","year":"2001","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.antiviral.2020.104870_bib43","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20061305","article-title":"The therapeutic potential of apigenin","volume":"20","author":"Salehi","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.antiviral.2020.104870_bib44","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.micres.2018.06.010","article-title":"Matricaria genus as a source of antimicrobial agents: from farm to pharmacy and food applications","volume":"215","author":"Sharifi-Rad","year":"2018","journal-title":"Microbiol. Res."},{"key":"10.1016\/j.antiviral.2020.104870_bib45","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1000085","article-title":"Cellular proteins in influenza virus particles","volume":"4","author":"Shaw","year":"2008","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.antiviral.2020.104870_bib46","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.virol.2014.05.024","article-title":"The flavonoid apigenin inhibits hepatitis C virus replication by decreasing mature microRNA122 levels","volume":"462\u2013463","author":"Shibata","year":"2014","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2020.104870_bib47","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1002\/hep.28679","article-title":"The liver-specific microRNA-122*, the complementary strand of microRNA-122, acts as a tumor suppressor by modulating the p53\/mouse double minute 2 homolog circuitry","volume":"64","author":"Simerzin","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.antiviral.2020.104870_bib48","first-page":"1561","article-title":"Role of cidofovir in the treatment of DNA virus infections, other than CMV infections, in immunocompromised patients","volume":"3","author":"Snoeck","year":"2002","journal-title":"Curr. Opin. Invest. Drugs"},{"key":"10.1016\/j.antiviral.2020.104870_bib49","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.ijcard.2019.11.090","article-title":"Liver-specific microRNA-122 as prognostic biomarker in patients with chronic systolic heart failure","volume":"303","author":"Stojkovic","year":"2020","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.antiviral.2020.104870_bib50","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1038\/cr.2012.129","article-title":"Coxsackievirus mutants that can bypass host factor PI4KIIIbeta and the need for high levels of PI4P lipids for replication","volume":"22","author":"van der Schaar","year":"2012","journal-title":"Cell Res."},{"key":"10.1016\/j.antiviral.2020.104870_bib51","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1080\/14786419.2015.1079188","article-title":"Phytochemical analysis of Achillea ligustica all. From lipari island (aeolian islands)","volume":"30","author":"Venditti","year":"2016","journal-title":"Nat. Prod. Res."},{"key":"10.1016\/j.antiviral.2020.104870_bib52","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.3109\/13880209.2014.991833","article-title":"Antioxidant and alpha-glucosidase inhibitory activities of Achillea tenorii","volume":"53","author":"Venditti","year":"2015","journal-title":"Pharm. Biol."},{"key":"10.1016\/j.antiviral.2020.104870_bib53","doi-asserted-by":"crossref","first-page":"5471","DOI":"10.1038\/s41598-018-23736-1","article-title":"Acute metabolic actions of the major polyphenols in chamomile: an in vitro mechanistic study on their potential to attenuate postprandial hyperglycaemia","volume":"8","author":"Villa-Rodriguez","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.antiviral.2020.104870_bib54","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1101\/gad.1185304","article-title":"Phosphorylation of eIF4E by Mnk-1 enhances HSV-1 translation and replication in quiescent cells","volume":"18","author":"Walsh","year":"2004","journal-title":"Genes Dev."},{"key":"10.1016\/j.antiviral.2020.104870_bib55","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s12929-016-0313-9","article-title":"Inhibition of Epstein-Barr virus reactivation by the flavonoid apigenin","volume":"24","author":"Wu","year":"2017","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.antiviral.2020.104870_bib56","doi-asserted-by":"crossref","first-page":"112279","DOI":"10.1016\/j.jep.2019.112279","article-title":"Polyalthia longifolia leaves methanolic extract targets entry and budding of viruses-an in vitro experimental study against paramyxoviruses","volume":"248","author":"Yadav","year":"2020","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.antiviral.2020.104870_bib57","doi-asserted-by":"crossref","first-page":"197836","DOI":"10.1016\/j.virusres.2019.197836","article-title":"Isolation and phylogenomic analysis of buffalopox virus from human and buffaloes in India","volume":"277","author":"Yadav","year":"2020","journal-title":"Virus Res."},{"key":"10.1016\/j.antiviral.2020.104870_bib58","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1172\/JCI200523220","article-title":"Antiviral chemotherapy facilitates control of poxvirus infections through inhibition of cellular signal transduction","volume":"115","author":"Yang","year":"2005","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.antiviral.2020.104870_bib59","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1186\/1743-422X-7-242","article-title":"Profiling of cellular proteins in porcine reproductive and respiratory syndrome virus virions by proteomics analysis","volume":"7","author":"Zhang","year":"2010","journal-title":"Virol. J."},{"key":"10.1016\/j.antiviral.2020.104870_bib60","article-title":"Apigenin inhibits enterovirus-71 infection by disrupting viral RNA association with trans-acting factors","volume":"9","author":"Zhang","year":"2014","journal-title":"PloS One"},{"key":"10.1016\/j.antiviral.2020.104870_bib61","first-page":"1560","article-title":"Apigenin suppresses the apoptosis of H9C2 rat cardiomyocytes subjected to myocardial ischemiareperfusion injury via upregulation of the PI3K\/Akt pathway","volume":"18","author":"Zhou","year":"2018","journal-title":"Mol. Med. Rep."}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354220302849?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354220302849?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T12:32:07Z","timestamp":1759062727000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354220302849"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":60,"alternative-id":["S0166354220302849"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2020.104870","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antiviral activity of Apigenin against buffalopox: Novel mechanistic insights and drug-resistance considerations","name":"articletitle","label":"Article Title"},{"value":"Antiviral Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.antiviral.2020.104870","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"104870"}}